GENERAL, O. Reg. 203/94

Schedule 2

Cite as GENERAL, O. Reg. 203/94, Schedule 2 · current to November 11, 2026 · consolidated from May 15, 2023 · read from e-Laws on November 16, 2026

The text

Schedule 2 drugs that may be prescribed by a member (Topical and oral) Drugs for Topical Use Topical Antibacterial Agents — for the purpose of managing superficial bacterial infections of the foot: Bacitracin Framycetin sulfate Fusidic acid Gentamicin sulfate Mupirocin Silver sulfadiazine Erythromycin Bacitracin/neomycin sulphate Neomycin sulphate/polymyxin B sulphate/bacitracin Neomycin sulphate/polymyxin B sulphate/gramicidin Topical Antifungal Agents — for the purpose of managing fungal and/or yeast infections of the skin and nails of the foot: Ciclopirox olamine Clotrimazole Ketoconazole Miconazole nitrate Nystatin Terbinafine HCl Tolnaftate cream Undecylenic acid Efinaconazole Clioquinol Topical Antipruritic and Local Anesthetic Agents — for the purpose of decreasing or eliminating sensation in an area of skin of the foot to relieve inflammatory skin symptoms or prior to injection or superficial procedures: Benzocaine Lidocaine Prilocaine Topical Nonsteroidal Anti-inflammatory Agents — for the purpose of relieving inflammation and pain in structures of the foot: Diclofenac Ketoprofen Piroxicam Sulindac Topical Corticosteroid Agents — for the purpose of treating inflammatory manifestations of corticosteroid responsive dermatoses in structures of the foot: Amcinonide Betamethasone diproprionate Betamethasone valerate Desoximetasone Flumethasone/clioquinol Fluocinonide Halcinonide Hydrocortisone Hydrocortisone 17 valerate Mometasone furoate Triamcinolone acetonide Topical Emollients, Keratolytic, and Miscellaneous Skin Agents — for the management of hyperkeratotic, inflammatory, and/or infectious skin conditions of the foot, adjunct treatment of fungal nails, and/or chemical destruction of miscellaneous skin and nail lesions: Salicylic Acid (70% or less) Urea (50% or less) Ammonium lactate (12% or less) Cantharidin (1% or less) Silver Nitrate (95% or less) 5-Fluorouracil (5% or less) Podophyllin (2% or less) Lactic acid (16.7% or less) Imiquimod (3.75% w/w) Pimercrolimus (1% w/w) Calcipotriol (50 mcg/g) Collagenase Drugs for Oral Use Oral Penicillin Antibacterial Agents — for the purpose of managing susceptible bacterial infections of foot wounds (traumatic, post-op complications), cellulitis, lacerations/punctures, abscesses, and/or surgical prophylaxis: Amoxicillin Amoxicillin/Clavulanic acid Cloxacillin Oral First-Generation Cephalosporin Agents — for the purpose of managing susceptible bacterial infections of foot wounds (traumatic, post-op complications), cellulitis, lacerations/punctures, abscesses, and/or surgical prophylaxis: Cefadroxil Cephalexin Oral Erythromycin and Macrolide Agents — for the purpose of managing susceptible bacterial infections of foot wounds (traumatic, post-op complications), cellulitis, lacerations/punctures, abscesses, and/or surgical prophylaxis: Erythromycin Azithromycin Clarithromycin Oral Quinolone Agents — for the purpose of managing susceptible bacterial infections of foot wounds (traumatic, post-op complications), cellulitis, lacerations/punctures, abscesses, and/or surgical prophylaxis: Ciprofloxacin Levofloxacin Moxifloxacin Oral Sulfonamide Agents — for the purpose of managing susceptible bacterial infections of foot wounds (traumatic, post-op complications), cellulitis, lacerations/punctures, abscesses, and/or surgical prophylaxis: Sulfamethoxazole/trimethoprim Oral Tetracycline Agents — for the purpose of managing susceptible bacterial infections of foot wounds (traumatic, post-op complications), cellulitis, lacerations/punctures, abscesses, and/or surgical prophylaxis: Tetracycline Doxycycline Oral Lincomycins — for the purpose of managing susceptible bacterial infections of foot wounds (traumatic, post-op complications), cellulitis, lacerations/punctures, abscesses, and/or surgical prophylaxis: Clindamycin Oral Metronidazole — for the purpose of managing susceptible anaerobic bacterial infections of foot wounds (traumatic, post-op complications), cellulitis, lacerations/punctures, and abscesses: Metronidazole Oral Nonsteroidal Anti-Inflammatory Agents — for the purpose of relieving inflammatory conditions or pain of the foot: Diclofenac potassium Diclofenac sodium Diflunisal Ibuprofen Indomethacin Meloxicam Ketorolac tromethamine (maximum daily dosage of 10 mg every 4-6 hours, as needed for pain, with the total dosage not to exceed 4 doses per day, or 40 mg in total per day, for a maximum duration of 5 days) Naproxen Naproxen sodium Tiaprofenic acid Celecoxib Ketoprofen Piroxicam Sulindac Oral Misoprostol — to be prescribed only in conjunction with Nonsteroidal Anti-inflammatory Agents for the purpose of preventing gastric bleeding, in the course of engaging in the practice of chiropody: Misoprostol Oral Azole Agents — for the purpose of managing fungal and/or yeast infections of the skin and nails of the foot: Itraconazole Fluconazole Oral Allylamine Agents — for the purpose of managing fungal and/or yeast infections of the skin and nails of the foot: Terbinafine Oral First-Generation Antihistamines — for use in the management of nausea/vomiting, pruritis, urticaria, and/or allergic symptomatology, in the course of engaging in the practice of chiropody: Diphenhydramine Promethazine Hydroxyzine Oral Second-Generation Antihistamines — for use in the management of pruritis, urticaria, and/or allergic symptomatology, in the course of engaging in the practice of chiropody: Cetirizine Oral Histamine H2-Antagonists — to be prescribed only in conjunction with Nonsteroidal Anti-inflammatory Agents for the purpose of preventing gastric bleeding, in the course of engaging in the practice of chiropody: Cimetidine Nizatidine
Read the GENERAL on e-Laws ↗

Made under Chiropody Act, 1991, S.O. 1991, c. 20.